TMEM232
Transmembrane protein 232
Also known as: FLJ43080, TM232_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- C9JQI7
- Gene
- TMEM232
- Ensembl
- ENSG00000186952
- Chromosome
- 5
- Canonical length
- 657 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
Predicted to be involved in flagellated sperm motility and spermatid cytoplasm removal during spermiation of flagellated sperm. Predicted to act upstream of or within maintenance of protein complex location. Predicted to be located in membrane. Predicted to be active in outer dense fiber. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
657 residues, UniProt reviewed canonical sequence.
>C9JQI7|TMEM232
1 MNMPVNKSPM INTCGGISSP YHEELWKLNF QHLSGERGHK SRPTFSITKE FILRFNQTQN
61 SKEKEELLEL ARKIILRCKR KLGLKTLGSG RHVHLPAAWT EVIYLAQCKG EIQDESLNML
121 YASLDHASFD YDHLPALFFV AESVLYRLCC DASLKTYLYS VEIKLAKIGY LVFLRLFIFF
181 LHGHLESFKQ HLLRLQPYLY ALSFSGASYH KYPNIFSNVQ FILKASEIIG KRELRSESIF
241 RPVEDKKRYE NTDSDMGGYE INHLLWHCVA AWSCVQNNSP QLNNVLEHLV FHKTQLQKKC
301 WLDSVLALLV LGEAAKLNMA CLKALMDVVR DFVSSIMSVQ NQEESCKVDD FSWAWNVVYI
361 YTVILAEICL YAATSDLRKT ALIGFCHCKS SQKNILYLDK SVPPELKETS ILSLLEYFSS
421 KMSENCDQVV WTGYYGLVYN LVKISWELQG DEEQDGLRNM IWQTLQKTKD YEEDVRIQNA
481 INIAQAELND PTDPFTRYST NISSNVGEEV FSKYIGWRIA NTLSKLFFPP IEAHFLPLKK
541 PSIKKDQTKY PNKKLESVKK QVLHFTVREH PSVSEIPMFP YPDFFTKADK ELAKIIDHHW
601 QEELKIREKE DAICKAQELK DKKLAEKNHF QEVMKKREEK LHKQTKPYEL PYRKEVILocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMEM232 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 16 nTPM
Expression across tissuesHPA
Tissue
- testis: 16 nTPM
- fallopian tube: 14 nTPM
- thyroid gland: 3.5 nTPM
- kidney: 3.4 nTPM
- retina: 3.3 nTPM
- choroid plexus: 3.2 nTPM
Single-cell type
- ependymal cells: 3,598 nCPM
- respiratory ciliated cells: 1,965 nCPM
- choroid plexus epithelial cells: 1,197 nCPM
- endometrial ciliated cells: 930 nCPM
- fallopian tube ciliated cells: 866 nCPM
- epididymal efferent duct ciliated cells: 591 nCPM
Immune cell
- memory B-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- choroid plexus: 23 nTPM
- midbrain: 23 nTPM
- medulla oblongata: 20 nTPM
- spinal cord: 17 nTPM
- white matter: 16 nTPM
- pons: 12 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.08
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.07
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell projection organization
- flagellated sperm motility
- maintenance of protein complex location
- spermatid cytoplasm removal during spermiation of flagellated sperm
- spermatogenesis
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Transmembrane protein 232
- Transmembrane protein family 232
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMEM232 as an antibody target. Whether an autoantibody or antibody against TMEM232 could matter depends on whether native TMEM232 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMEM232 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TMEM232 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...